Department of Chemotherapy for Malignant Tumors and Palliative Care

The Department of Chemotherapy for Malignant Tumors and Palliative Care is actively engaged in the treatment of patients with various forms of cancer, including both solid tumors and hematologic malignancies. The main areas of activity in the department include:

            1. Chemotherapy for Solid Tumors: Patients with tumors in various locations receive treatment according to international protocols. The latest chemotherapy regimens are used, including combinations of cytostatics, targeted therapies, and immunotherapies, allowing for more precise impact on the tumor.

            2. Hematologic Malignancies: Patients with blood diseases, such as lymphomas, multiple myeloma, and Hodgkin’s disease, are treated with high-dose chemotherapy. The department also prepares patients for stem cell transplants, which is a crucial step in the treatment of malignant blood diseases.

            3. Targeted Therapy: Emphasis is placed on the use of targeted drugs that selectively act on tumor cells, minimizing damage to healthy tissues. This reduces side effects and increases treatment effectiveness.

            4. Immunotherapy: In addition to traditional chemotherapy methods, immunotherapy is increasingly used — utilizing drugs that activate the immune system to fight cancer cells. This cutting-edge approach in oncology has shown high efficacy for many types of cancer.

            5. Continuous Infusion Therapy: Systems for continuous drug administration (infusion pumps) are used to maintain stable concentrations of chemotherapy agents in the blood. This method avoids sharp fluctuations in drug levels in the blood and reduces treatment toxicity.

            6. Palliative Care: Special attention is given to palliative care for patients with advanced cancer stages. This care focuses on improving the quality of life, managing pain and other symptoms, and providing psychological support. Palliative care is provided both in inpatient settings and at home.

            7. Complication Prevention: Methods to prevent complications associated with long-term chemotherapy are actively applied, such as phlebitis and thrombophlebitis prevention. Subclavian vein catheterization enables safe and effective infusion therapy without the need for frequent vein access changes.

            8. Phytotherapy: As part of a comprehensive treatment approach, phytotherapy is incorporated into the department’s practice, helping to reduce the side effects of chemotherapy and support the patient’s body throughout treatment. Phyto-oncology has become an important complement to traditional therapy methods.

The department is staffed with highly qualified medical professionals, including 11 doctors, of whom 3 hold the highest qualification category, 2 hold a candidate in medical sciences, and 2 are first-category physicians, with one doctor holding the second category. Physicians in the department are actively involved in research, developing new approaches to the treatment of malignant tumors and implementing innovative diagnostic and therapeutic methods.